Alivus Life Sciences Ltd vs Blue Jet Healthcare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Alivus Life Sciences Ltd is ₹ 1056 as of 18 May 13:14 . The P/E Ratio of Alivus Life Sciences Ltd is 0 as of March 2021 .The P/E Ratio of Blue Jet Healthcare Ltd is 0 as of March 2021 . The Market Cap of Alivus Life Sciences Ltd is ₹ 0 crore as of March 2021 .The Market Cap of Blue Jet Healthcare Ltd is ₹ 0 crore as of March 2021 . The revenue of Alivus Life Sciences Ltd for the Mar '26 is ₹ 711.9 crore as compare to the Dec '25 revenue of ₹ 686.82 crore. This represent the growth of 3.65% The revenue of Blue Jet Healthcare Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 205.62 crore. This represent the decline of -100% The ebitda of Alivus Life Sciences Ltd for the Mar '26 is ₹ 237.31 crore as compare to the Dec '25 ebitda of ₹ 219.54 crore. This represent the growth of 8.09% The ebitda of Blue Jet Healthcare Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 60.1 crore. This represent the decline of -100% The net profit of Alivus Life Sciences Ltd changed from ₹ 111.48 crore to ₹ 162.66 crore over 8 quarters. This represents a CAGR of 20.79% The net profit of Blue Jet Healthcare Ltd changed from ₹ 37.78 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 12.62 % on March 2025 . This represents a CAGR of -32.68% over 4 yearsThe Dividend Payout of Blue Jet Healthcare Ltd changed from 10.59 % on March 2024 to 6.82 % on March 2025 . This represents a CAGR of -19.75% over 2 years .

About Alivus Life Sciences Ltd

Alivus Life Sciences Limited was initially established as 'Zorg Laboratories Private Limited', on June 23, 2011 and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune.
Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The name of the Company has now changed to 'Alivus Life Sciences Limited' on January 20, 2025. Nirma Limited is a Subsidiary of the Company.
The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs). In 2001, Glenmark Pharmaceuticals established its API business.

About Blue Jet Healthcare Ltd

Blue Jet Healthcare Limited was originally incorporated as Jet Chemicals Private Limited,' at Mumbai, dated December 7, 1968.
The Company name was changed to Blue Jet Healthcare Private Limited', and a fresh Certificate of Incorporation dated December 30, 2020, was issued by the Registrar of Companies, Mumbai.
Subsequently, the status got converted into a Limited Company and its name was changed to Blue Jet Healthcare Limited' on May 18, 2022. The Company is a global, science-led, pharmaceutical company evolved as strategic partner for Collaboration, Development & Manufacturing of Advance Pharmaceutical Intermediates and API. It operate into 3 product categories, contrast media intermediates, high- intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs).

FAQs for the comparison of Alivus Life Sciences Ltd and Blue Jet Healthcare Ltd

Which company has a larger market capitalization, Alivus Life Sciences Ltd or Blue Jet Healthcare Ltd?

Market cap of Alivus Life Sciences Ltd is 12,824 Cr while Market cap of Blue Jet Healthcare Ltd is 7,458 Cr

What are the key factors driving the stock performance of Alivus Life Sciences Ltd and Blue Jet Healthcare Ltd?

The stock performance of Alivus Life Sciences Ltd and Blue Jet Healthcare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alivus Life Sciences Ltd and Blue Jet Healthcare Ltd?

As of May 18, 2026, the Alivus Life Sciences Ltd stock price is INR ₹1044.85. On the other hand, Blue Jet Healthcare Ltd stock price is INR ₹429.95.

How do dividend payouts of Alivus Life Sciences Ltd and Blue Jet Healthcare Ltd compare?

To compare the dividend payouts of Alivus Life Sciences Ltd and Blue Jet Healthcare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.